BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24889603)

  • 1. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor.
    Lim SM; Westover KD; Ficarro SB; Harrison RA; Choi HG; Pacold ME; Carrasco M; Hunter J; Kim ND; Xie T; Sim T; Jänne PA; Meyerson M; Marto JA; Engen JR; Gray NS
    Angew Chem Int Ed Engl; 2014 Jan; 53(1):199-204. PubMed ID: 24259466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules.
    Goody RS; Müller MP; Rauh D
    Cell Chem Biol; 2019 Oct; 26(10):1338-1348. PubMed ID: 31378709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
    Ostrem JM; Peters U; Sos ML; Wells JA; Shokat KM
    Nature; 2013 Nov; 503(7477):548-51. PubMed ID: 24256730
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Pálfy G; Vida I; Perczel A
    Biomol NMR Assign; 2020 Apr; 14(1):1-7. PubMed ID: 31468366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.
    Gentile DR; Rathinaswamy MK; Jenkins ML; Moss SM; Siempelkamp BD; Renslo AR; Burke JE; Shokat KM
    Cell Chem Biol; 2017 Dec; 24(12):1455-1466.e14. PubMed ID: 29033317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
    Zhang B; Zhang Y; Shacter E; Zheng Y
    Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
    Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
    J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
    Scheffzek K; Ahmadian MR; Kabsch W; Wiesmüller L; Lautwein A; Schmitz F; Wittinghofer A
    Science; 1997 Jul; 277(5324):333-8. PubMed ID: 9219684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G proteins, effectors and GAPs: structure and mechanism.
    Sprang SR
    Curr Opin Struct Biol; 1997 Dec; 7(6):849-56. PubMed ID: 9434906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for the transition from Ras-GTP to Ras-GDP.
    Hall BE; Bar-Sagi D; Nassar N
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RAS: proven and potential vulnerabilities.
    Zuberi M; Khan I; O'Bryan JP
    Biochem Soc Trans; 2020 Oct; 48(5):1831-1841. PubMed ID: 32869838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of Ral-GppNHp and Ral-GDP reveal two binding sites that are also present in Ras and Rap.
    Nicely NI; Kosak J; de Serrano V; Mattos C
    Structure; 2004 Nov; 12(11):2025-36. PubMed ID: 15530367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue.
    Ihara K; Muraguchi S; Kato M; Shimizu T; Shirakawa M; Kuroda S; Kaibuchi K; Hakoshima T
    J Biol Chem; 1998 Apr; 273(16):9656-66. PubMed ID: 9545299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the unique biological function of small GTPase RHEB.
    Yu Y; Li S; Xu X; Li Y; Guan K; Arnold E; Ding J
    J Biol Chem; 2005 Apr; 280(17):17093-100. PubMed ID: 15728574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What makes Ras an efficient molecular switch: a computational, biophysical, and structural study of Ras-GDP interactions with mutants of Raf.
    Filchtinski D; Sharabi O; Rüppel A; Vetter IR; Herrmann C; Shifman JM
    J Mol Biol; 2010 Jun; 399(3):422-35. PubMed ID: 20361980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPases.
    Ye M; Shima F; Muraoka S; Liao J; Okamoto H; Yamamoto M; Tamura A; Yagi N; Ueki T; Kataoka T
    J Biol Chem; 2005 Sep; 280(35):31267-75. PubMed ID: 15994326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent Guanosine Mimetic Inhibitors of G12C KRAS.
    Xiong Y; Lu J; Hunter J; Li L; Scott D; Choi HG; Lim SM; Manandhar A; Gondi S; Sim T; Westover KD; Gray NS
    ACS Med Chem Lett; 2017 Jan; 8(1):61-66. PubMed ID: 28105276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site.
    Kearney BM; Johnson CW; Roberts DM; Swartz P; Mattos C
    J Mol Biol; 2014 Feb; 426(3):611-29. PubMed ID: 24189050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-Deoxy Guanosine Nucleotides Alter the Biochemical Properties of Ras.
    Yun SD; Scott E; Moghadamchargari Z; Laganowsky A
    Biochemistry; 2023 Aug; 62(16):2450-2460. PubMed ID: 37487239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.